Skip to main content
Premium Trial:

Request an Annual Quote

Strand, India's MSCC Partner on Translation Cancer Research

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Informatics firm Strand Life Sciences announced on Wednesday it has signed a memorandum of understanding focused on translational cancer research with India's Mazumdar Shaw Comprehensive Cancer Centre of the Narayana Hrudalaya.

Specifically, the partnership includes joint research and training in translational cancer using genomics and proteomics.

The partners have begun a pilot project studying head and neck cancer, one of the most prevalent types of cancer in India, Strand said in a statement. According to Binay Panda, senior vice president of Strand and head of Ganit Labs — a state of the art functional genomics and next-generation sequencing center in Bangalore, India — the collaboration brings together for the first time in that country scientists from fields as diverse as computer science, head and neck surgery, and genome biology for comprehensive research work.

Strand, which has offices in Bangalore and San Francisco, is a participant in the public-private initiative to create Ganit Labs.

Terms of the deal were not disclosed.

The Scan

Nature Papers Examine Genomes of Centenarians, Transcription-Coupled DNA Repair

In Nature this week: analysis of centenarian genomes uncovers longevity-linked variants, and more.

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.